154 related articles for article (PubMed ID: 32650510)
1. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from
Tran HT; Solnier J; Pferschy-Wenzig EM; Kunert O; Martin L; Bhakta S; Huynh L; Le TM; Bauer R; Bucar F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32650510
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
Solnier J; Martin L; Bhakta S; Bucar F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
[TBL] [Abstract][Full Text] [Related]
3. Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.
Jin J; Zhang JY; Guo N; Sheng H; Li L; Liang JC; Wang XL; Li Y; Liu MY; Wu XP; Yu L
Molecules; 2010 Oct; 15(11):7750-62. PubMed ID: 21042264
[TBL] [Abstract][Full Text] [Related]
4. Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
Gröblacher B; Maier V; Kunert O; Bucar F
J Nat Prod; 2012 Jul; 75(7):1393-9. PubMed ID: 22789014
[TBL] [Abstract][Full Text] [Related]
5. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
Lechner D; Gibbons S; Bucar F
J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
[TBL] [Abstract][Full Text] [Related]
6. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
[TBL] [Abstract][Full Text] [Related]
7. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
Rai D; Mehra S
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
Piddock LJ; Williams KJ; Ricci V
J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antiproliferative compounds from Sphaeranthus africanus.
Tran HT; Gao X; Kretschmer N; Pferschy-Wenzig EM; Raab P; Pirker T; Temml V; Schuster D; Kunert O; Huynh L; Bauer R
Phytomedicine; 2019 Sep; 62():152951. PubMed ID: 31136898
[TBL] [Abstract][Full Text] [Related]
10. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis.
Jin J; Zhang J; Guo N; Feng H; Li L; Liang J; Sun K; Wu X; Wang X; Liu M; Deng X; Yu L
J Med Microbiol; 2011 Feb; 60(Pt 2):223-229. PubMed ID: 21051548
[TBL] [Abstract][Full Text] [Related]
11. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
[TBL] [Abstract][Full Text] [Related]
12. Efflux Pump Inhibition and Resistance Modulation in
Šimunović K; Solnier J; Alperth F; Kunert O; Smole Možina S; Bucar F
Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572657
[TBL] [Abstract][Full Text] [Related]
13. 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
Roy SK; Kumari N; Gupta S; Pahwa S; Nandanwar H; Jachak SM
Eur J Med Chem; 2013 Aug; 66():499-507. PubMed ID: 23832254
[TBL] [Abstract][Full Text] [Related]
14. Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
Gröblacher B; Kunert O; Bucar F
Bioorg Med Chem; 2012 Apr; 20(8):2701-6. PubMed ID: 22459211
[TBL] [Abstract][Full Text] [Related]
15. Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.
Agre N; Khambete M; Maitra A; Gupta A; Munshi T; Bhakta S; Degani M
Chem Biol Drug Des; 2020 Jan; 95(1):192-199. PubMed ID: 31560814
[TBL] [Abstract][Full Text] [Related]
16. Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium.
Machado D; Cannalire R; Santos Costa S; Manfroni G; Tabarrini O; Cecchetti V; Couto I; Viveiros M; Sabatini S
ACS Infect Dis; 2015 Dec; 1(12):593-603. PubMed ID: 27623057
[TBL] [Abstract][Full Text] [Related]
17. Essential Oil, Extracts, and Sesquiterpenes Obtained From the Heartwood of
Espinoza J; Urzúa A; Sanhueza L; Walter M; Fincheira P; Muñoz P; Mendoza L; Wilkens M
Front Microbiol; 2019; 10():337. PubMed ID: 30863385
[No Abstract] [Full Text] [Related]
18. Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.
Fomogne-Fodjo MC; Ndinteh DT; Olivier DK; Kempgens P; van Vuuren S; Krause RW
J Ethnopharmacol; 2017 Jan; 195():238-245. PubMed ID: 27864111
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Carvotacetones from Sphaeranthus africanus Against Cancer Cells and Their Potential to Induce Apoptosis.
Tran HT; Kretschmer N; Huynh L; Bauer R
Planta Med; 2023 May; 89(6):624-636. PubMed ID: 36720230
[TBL] [Abstract][Full Text] [Related]
20. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]